Company’s Capital and Strategic Focus Now Entirely Directed at IM8
IM8 FY 2026 Revenue Forecast to Hit $180 – $200 Million
CHARLOTTE, N.C., Dec. 30, 2025 — Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a leading health sciences firm and parent of the IM8 premium health and longevity brand, today announced a strategic realignment to fully leverage the rapid expansion of its consumer health brand, IM8. Prenetics halted its daily Bitcoin buying activity as of December 4, 2025, and following approval from its Board of Directors, Prenetics confirmed it will no longer pursue future Bitcoin acquisitions. This decision enables Prenetics to channel its resources and focus exclusively on the substantial market opportunity presented by IM8.
This strategic shift comes amid unprecedented success for IM8 in the consumer wellness sector. As the fastest-growing supplement brand in industry history, IM8 achieved over $100 million in annualized recurring revenue (“ARR”) within 11 months of its launch.
Danny Yeung, CEO and Co-Founder of Prenetics, commented, “The remarkable success of IM8 has surpassed all projections and grown far more quickly than our initial forecasts. Our Board and management team are in full agreement that the most promising route to generating significant, sustainable shareholder value is to dedicate our full attention to this once-in-a-generation opportunity clearly evident in IM8. We are extremely enthusiastic about IM8’s future and confident that by concentrating our efforts, we can drive its growth to even greater levels. Operating from a position of strength, we are making disciplined strategic choices that reflect our experience as operators and our commitment to maximizing long-term shareholder value.”
The Company maintains a sturdy financial position, supported by a strong balance sheet featuring over $70 million in cash and cash equivalents, 510 BTC, and no debt. This financial stability provides a solid base for the Company’s focused expansion of IM8.
Following Board approval, Prenetics will keep its existing Bitcoin holdings of 510 BTC as a treasury reserve asset. Prenetics has committed to not allocating any existing or new capital for additional Bitcoin purchases. Capital allocation will be directed solely toward the growth, operations, and strategic expansion of IM8, covering product innovation, brand development, talent recruitment, working capital, and international expansion.
Prenetics believes this decision enhances strategic clarity, reinforces disciplined governance, and fully aligns the Company with shareholder priorities as it continues to scale IM8 globally.
About Prenetics
Prenetics (NASDAQ: PRE) is a leading health sciences company redefining the future of health and longevity through IM8—its flagship consumer brand co-founded with David Beckham and championed by World No. 1 and four-time Grand Slam winner Aryna Sabalenka. IM8 has achieved the fastest growth trajectory in supplement industry history, reaching $100 million+ in ARR within 11 months of launch, outpacing even leading AI startups.
About IM8
IM8 represents the pinnacle of premium core nutrition, emerging from a collaboration between David Beckham as a co-founding partner and an elite team of scientists spanning medical professionals, academia, and space science. Blending cutting-edge science with nature’s most powerful ingredients, IM8 offers a holistic, science-backed approach to health, empowering individuals to live their most vibrant lives. IM8’s flagship product, Daily Ultimate Essentials, is an all-in-one powder supplement designed to replace 16 different supplements in a delicious drink. It is NSF Certified for Sport, non-GMO, vegan, free from common allergens, and contains no artificial flavors, colors, or sweeteners. IM8 is a subsidiary of Prenetics (NASDAQ: PRE), a leading global health sciences company dedicated to advancing consumer health. To learn more about IM8, visit www.IM8health.com.
Investor Relations Contact
investors@prenetics.com
PRE@mzgroup.us
Angela Cheung
Investor Relations / Corporate Finance
angela.hm.cheung@prenetics.com
Forward-Looking Statements
This press release includes forward-looking statements. These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. Statements that are not historical facts—including those about the Company’s goals, targets, projections, outlooks, beliefs, expectations, strategy, plans, management objectives for future operations, and growth opportunities—are forward-looking statements. Our guidance reflects management’s current estimates and assumptions as of the date of this release, is subject to substantial risks and uncertainties, and does not guarantee future performance. Actual results may vary significantly. In some cases, forward-looking statements can be identified by terms such as “may,” “will,” “expect,” “anticipate,” “target,” “aim,” “estimate,” “intend,” “plan,” “believe,” “potential,” “continue,” “is/are likely to,” “guidance,” “outlook,” “forecast,” or similar expressions. Forward-looking statements are based on estimates and forecasts and reflect the Company’s views, assumptions, expectations, and opinions, which involve inherent risks and uncertainties, and thus should not be relied upon as necessarily indicative of future results. A number of factors could cause actual results to differ materially from those in any forward-looking statement, including but not limited to: future alpha-generating activities involving the Company’s Bitcoin holdings could expose it to additional risks; the Company’s Bitcoin purchases subject it to risks related to Bitcoin’s extreme volatility and speculative nature; the Company may fail to maintain and enhance its IM8 business and brand if it faces negative publicity, fails to retain a strong base of engaged customers and content creators, or otherwise fails to meet customer expectations; the Company’s ability to further develop and grow its business, including new products and services; and its ability to identify and execute M&A opportunities. In addition to these factors, you should also carefully consider the other risks and uncertainties described in the “Risk Factors” section of the Company’s most recent registration statement and prospectus, and other documents filed by the Company with the U.S. Securities and Exchange Commission from time to time. Unless otherwise specified, all information in this press release is as of the date of this release, and the Company has no obligation to update such information, except as required by applicable law.
